LABStandard BioTools Inc.

$370M

Q2 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$24M-15.1% YoY

Gross Profit

$12M50.0% margin

Operating Income

-$16M-68.9% margin

Net Income

-$17M-70.8% margin

EPS (Diluted)

$-0.58

QoQ Revenue Growth

-6.3%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$279M

Total Liabilities

$255M

Stockholders' Equity

$24M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$28M	-15.1%
Gross Profit	$12M	$16M	-23.8%
Operating Income	-$16M	-$18M	+9.1%
Net Income	-$17M	-$19M	+9.0%

Geographic Segments

UNITED STATES

$12M49%

Europe

$8M32%

Asia Pacific

$4M16%

Other Geographical Countries

$624,0003%

LAB Q2 2017 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena